Danaher Corp (DHR) - Medical Equipment - Deals and Alliances Profile

Danaher Corp (DHR) - Medical Equipment - Deals and Alliances Profile


  • Products Id :- GDME575D
  • |
  • Pages: 146
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Danaher Corp (Danaher) is a medical technology company which designs, manufactures and markets medical, professional, commercial and industrial products and services. It offers a wide range of testing instruments, communications solutions, water quality systems, medical diagnostics solutions, life science research tools, professional microscopes, dental products, product identification solutions, automation solutions and sensors and controls solutions. The company operates manufacturing, sales, distribution, service and administrative facilities in Europe, Australia, Asia and the Americas. The company distributes its products to its customers across the Americas; Europe, Middle East, Africa and Asia-Pacific through direct sales personnel and independent distributors. Danaher is headquartered in Washington DC, the US.

Danaher Corp (DHR)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 6

List of Figures 7

Danaher Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 9

Danaher Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 10

Danaher Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 11

Danaher Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 12

Danaher Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 13

Danaher Corp, Medical Equipment, Deal Details 18

Asset Purchase 18

Beckman Coulter Acquires Clinical Microbiology Business from Siemens Healthcare Diagnostics 18

Devicor Medical Products Acquires Hydromark Breast Biopsy Marker Portfolio And Related Assets From Biopsy Sciences 20

Venture Financing 21

H2O TECH Secures Investment In Venture Financing 21

Partnerships 22

Leica Biosystems Enters into Licensing Agreement with Arno Therapeutics 22

Cell Signaling Technology Enters Into Licensing Agreement With Cepheid For Personalized Cancer Diagnostics 23

Smart Imaging Enters Into Licensing Agreement With Leica Microsystems 24

Prosolia Enters Into Licensing Agreement With AB Sciex For ORNL Analytical Technology 25

Thermo Fisher and Leica Microsystems Enter into Partnership 26

AB Sciex Enters into Co-Marketing Agreement with IROA Technologies 27

Leica Biosystems Enters into Distribution Agreement with Kub Technologies 28

Clearbridge Enters into Agreement with Leica Biosystems 29

Clearbridge BioMedics and Leica Biosystems Enter into Co-Marketing Partnership 30

SCIEX forms Joint Venture with Zhejiang Dian Diagnostics in China 31

Nobel Biocare Enters into Agreement with Dentalpoint 32

Grifols and Beckman Coulter Enter into Distribution Agreement 33

SpeeDx Enters into Distribution Agreement with Cepheid 34

Bayer Enters into Co-Development Agreement with Leica Biosystems 35

Novacyt Enters into Partnership with Cepheid 36

DiaSorin Enters into Agreement with Beckman Coulter 37

Devicor Medical Products Enters into Distribution Agreement with Endomagnetics 38

Leica Biosystems Enters into Co-Development Agreement with Merrimack Pharma 39

AB Sciex Enters into Agreement with QPS Holdings 40

Leica Biosystems Enters into Agreement with Advanced Cell Diagnostics 41

Cepheid, MedImmune and Combacte Enter into Agreement 42

AB Sciex Enters into Co-Marketing Agreement with Pressure BioSciences 43

Cepheid Enters into Agreement with Foundation for Innovative New Diagnostics 44

Sidney Kimmel Cancer Center Enters into Agreement with Cepheid 45

RareCyte Enters into Co-Marketing Agreement with Leica Biosystems 46

Vomaris Innovations Enters into Distribution Agreement with Metrex Research 47

DiaSorin Enters into Distribution Agreement with Beckman Coulter Diagnostics 48

Ab Sciex Enters into Co-Marketing Agreement with Hepregen 49

NanoCellect Biomedical Enters into Co-Development Agreement with Invetech 50

Bio-Rad Labs Extends Agreement with Beckman Coulter Diagnostics 51

NeoStem Enters into Co-Development Agreement with Invetech 52

Leica Biosystems Nussloch Partners with NovoPath 53

Leica Biosystems Nussloch Partners with Mayo Clinic 54

Foundation for Innovative New Diagnostics Enters into Agreement with Cepheid and Rutgers 55

Ab Sciex Enters into Co-Development Agreement with Dalton Pharma 56

Leica Biosystems Enters into Co-Marketing Agreement with Advanced Cell Diagnostics 57

Leica Biosystems Enters into Co-Development Agreement with Bristol-Myers Squibb 58

Cepheid Enters into Co-Development Agreement with AstraZeneca, Cubist Pharma and GSK 59

Devicor Medical Products Enters Into Distribution Agreement With Faxitron Bioptics For CoreVision 60

Invetech Enters Into Co-Development Agreement With Biocartis For Evalution 61

Arno Therapeutics Enters Into Co-Development Agreement With Leica Biosystems 62

Ab Sciex, Genedata And Leco Enter Into Agreement For Metabolomics Data Analysis Solution 63

Leica Microsystems Enters Into Distribution Agreement With Bausch & Lomb 64

Leica Biosystems Enters Into Agreement With Aspera For Data Distribution Solution 65

CellaVision Expands Distribution Agreement With Beckman Coulter 66

Leica Biosystems And Synthon Biopharma Enter Into Agreement To Develop Companion Diagnostic Test For Targeted Cancer Therapies 67

Cepheid Enters Into Co-Development Agreement With Oregon Health and Science University 68

Galena Biopharma Enters Into Co-Development Agreement With Leica Biosystems 69

IRIS International Enters Into Distribution Agreement With Alifax 70

Leica Microsystems Enters Into Integration Agreement With Indica Labs 71

Affymetrix Enters Into Technology Integration Agreement With Leica Microsystems 72

Radisens Diagnostics Enters Into Co-Development Agreement With Beckman Coulter For HDR Detection Technology 73

Devicor Medical Products Enters Into Co-Marketing Agreement With Carbon Medical Technologies 74

Iris International Enters Into Distribution Agreement With Fisher HealthCare 75

Merger 76

Molecular Devices and ForteBio Complete Merger to Form Biologics Solutions 76

Equity Offering 77

Danaher Plans to Raise Funds through Public Offering of Securities 77

Debt Offering 78

Danaher Raises USD279.8 Million in Public Offering of Floating Rate Notes Due 2022 78

Danaher Raises USD671.6 Million in Public Offering of 1.2% Notes Due 2027 80

Danaher Raises USD500 Million in Public Offering of 1.65% Notes Due 2018 82

Danaher Raises USD500 Million in Public Offering of 3.35% Notes Due 2025 84

Danaher Raises USD500 Million in Public Offering of 2.4% Notes Due 2020 86

Danaher Raises USD500 Million in Public Offering of 4.375% Notes Due 2045 88

Danaher Raises USD500 Million in Public Offering of Notes Due 2017 90

Danaher Raises USD671 Million in Public Offering of 1% Notes Due 2019 92

Danaher Raises USD894.5 Million in Public Offering of 2.5% Notes Due 2025 94

Danaher Raises USD894.5 Million in Public Offering of 1.7% Notes Due 2022 96

Cepheid Completes Private Placement Of Notes Due 2021 For USD 345 Million 98

Asset Transactions 100

GENEWIZ to Acquire Genomic Services Business of Beckman Coulter 100

Haemonetics Completes Acquisition Of Blood Collection, Filtration And Processing Product Lines From Pall For USD 551 Million 101

Acquisition 103

Danaher to Acquire Integrated DNA Technologies 103

Danaher Acquires Phenomenex 104

Danaher Acquires Cepheid 105

Danaher Acquires Pall for USD13.8 Billion 107

Leica Microsystems to Acquire Bioptigen 109

Danaher Acquires 97% Stake in Nobel Biocare for USD2.17 Billion in Tender Offer 110

Leica Biosystems Nussloch Acquires Devicor Medical from GTCR 112

Leica Biosystems Acquires Kreatech Diagnostics 113

Leica Microsystems And Leica Biosystems Acquire Aotec Instrumentos 114

Quest Diagnostics Completes Sale Of HemoCue To Radiometer Medical For USD 300 Million 115

Danaher Completes Acquisition Of 91.6% Stake In Iris International, Diagnostic Test Maker, For USD 324 Million 117

Leica Biosystems Completes Acquisition Of Aperio Technologies 119

Beckman Coulter Acquires Blue Ocean Biomedical From Npe Systems 121

Pall Corporation Completes Acquisition Of ForteBio For USD 142.5 Million 122

Danaher Corp-Key Competitors 124

Danaher Corp-Key Employees 125

Danaher Corp-Locations And Subsidiaries 126

Head Office 126

Other Locations & Subsidiaries 126

Business Unit 133

Recent Developments 134

Financial Announcements 134

Apr 19, 2018: Danaher Announces First Quarter 2018 Results 134

Mar 07, 2018: Danaher Provides Update on First Quarter 2018 Financial Performance 135

Jan 30, 2018: Danaher Reports Fourth Quarter And Full Year 2017 Results 136

Oct 19, 2017: Danaher Reports Third Quarter 2017 Results 137

Jul 20, 2017: Danaher Reports Second Quarter 2017 Results 138

Apr 20, 2017: Danaher Reports First Quarter 2017 Results 139

Jan 31, 2017: Danaher Reports Fourth Quarter And Full Year 2016 Results 140

Corporate Communications 141

Apr 25, 2018: Diebold Nixdorf Elects Board Members At Annual Shareholders Meeting 141

Jan 20, 2018: Danaher Announces Transition Plan for Chief Financial Officer 142

Nov 28, 2017: Danaher Announced its Leadership Appointment 143

Feb 21, 2017: Danaher Announces Appointment Of Raymond C. Stevens, Ph.D. To Danaher Board 144

Legal and Regulatory 145

Jul 19, 2018: Danaher announces plan to Spin off dental business into an independent, publicly traded company 145

Appendix 146

Methodology 146

About GlobalData 146

Contact Us 146

Disclaimer 146

List of Figures

Danaher Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Danaher Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Danaher Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Danaher Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Danaher Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 9

Danaher Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 10

Danaher Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 11

Danaher Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 12

List of Tables

Danaher Corp, Medical Equipment, Key Facts, 2017 2

Danaher Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Danaher Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 9

Danaher Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 10

Danaher Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 11

Danaher Corp, Deals By Market, 2012 to YTD 2018 12

Danaher Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 13

Beckman Coulter Acquires Clinical Microbiology Business from Siemens Healthcare Diagnostics 18

Devicor Medical Products Acquires Hydromark Breast Biopsy Marker Portfolio And Related Assets From Biopsy Sciences 20

H2O TECH Secures Investment In Venture Financing 21

Leica Biosystems Enters into Licensing Agreement with Arno Therapeutics 22

Cell Signaling Technology Enters Into Licensing Agreement With Cepheid For Personalized Cancer Diagnostics 23

Smart Imaging Enters Into Licensing Agreement With Leica Microsystems 24

Prosolia Enters Into Licensing Agreement With AB Sciex For ORNL Analytical Technology 25

Thermo Fisher and Leica Microsystems Enter into Partnership 26

AB Sciex Enters into Co-Marketing Agreement with IROA Technologies 27

Leica Biosystems Enters into Distribution Agreement with Kub Technologies 28

Clearbridge Enters into Agreement with Leica Biosystems 29

Clearbridge BioMedics and Leica Biosystems Enter into Co-Marketing Partnership 30

SCIEX forms Joint Venture with Zhejiang Dian Diagnostics in China 31

Nobel Biocare Enters into Agreement with Dentalpoint 32

Grifols and Beckman Coulter Enter into Distribution Agreement 33

SpeeDx Enters into Distribution Agreement with Cepheid 34

Bayer Enters into Co-Development Agreement with Leica Biosystems 35

Novacyt Enters into Partnership with Cepheid 36

DiaSorin Enters into Agreement with Beckman Coulter 37

Devicor Medical Products Enters into Distribution Agreement with Endomagnetics 38

Leica Biosystems Enters into Co-Development Agreement with Merrimack Pharma 39

AB Sciex Enters into Agreement with QPS Holdings 40

Leica Biosystems Enters into Agreement with Advanced Cell Diagnostics 41

Cepheid, MedImmune and Combacte Enter into Agreement 42

AB Sciex Enters into Co-Marketing Agreement with Pressure BioSciences 43

Cepheid Enters into Agreement with Foundation for Innovative New Diagnostics 44

Sidney Kimmel Cancer Center Enters into Agreement with Cepheid 45

RareCyte Enters into Co-Marketing Agreement with Leica Biosystems 46

Vomaris Innovations Enters into Distribution Agreement with Metrex Research 47

DiaSorin Enters into Distribution Agreement with Beckman Coulter Diagnostics 48

Ab Sciex Enters into Co-Marketing Agreement with Hepregen 49

NanoCellect Biomedical Enters into Co-Development Agreement with Invetech 50

Bio-Rad Labs Extends Agreement with Beckman Coulter Diagnostics 51

NeoStem Enters into Co-Development Agreement with Invetech 52

Leica Biosystems Nussloch Partners with NovoPath 53

Leica Biosystems Nussloch Partners with Mayo Clinic 54

Foundation for Innovative New Diagnostics Enters into Agreement with Cepheid and Rutgers 55

Ab Sciex Enters into Co-Development Agreement with Dalton Pharma 56

Leica Biosystems Enters into Co-Marketing Agreement with Advanced Cell Diagnostics 57

Leica Biosystems Enters into Co-Development Agreement with Bristol-Myers Squibb 58

Cepheid Enters into Co-Development Agreement with AstraZeneca, Cubist Pharma and GSK 59

Devicor Medical Products Enters Into Distribution Agreement With Faxitron Bioptics For CoreVision 60

Invetech Enters Into Co-Development Agreement With Biocartis For Evalution 61

Arno Therapeutics Enters Into Co-Development Agreement With Leica Biosystems 62

Ab Sciex, Genedata And Leco Enter Into Agreement For Metabolomics Data Analysis Solution 63

Leica Microsystems Enters Into Distribution Agreement With Bausch & Lomb 64

Leica Biosystems Enters Into Agreement With Aspera For Data Distribution Solution 65

CellaVision Expands Distribution Agreement With Beckman Coulter 66

Leica Biosystems And Synthon Biopharma Enter Into Agreement To Develop Companion Diagnostic Test For Targeted Cancer Therapies 67

Cepheid Enters Into Co-Development Agreement With Oregon Health and Science University 68

Galena Biopharma Enters Into Co-Development Agreement With Leica Biosystems 69

IRIS International Enters Into Distribution Agreement With Alifax 70

Leica Microsystems Enters Into Integration Agreement With Indica Labs 71

Affymetrix Enters Into Technology Integration Agreement With Leica Microsystems 72

Radisens Diagnostics Enters Into Co-Development Agreement With Beckman Coulter For HDR Detection Technology 73

Devicor Medical Products Enters Into Co-Marketing Agreement With Carbon Medical Technologies 74

Iris International Enters Into Distribution Agreement With Fisher HealthCare 75

Molecular Devices and ForteBio Complete Merger to Form Biologics Solutions 76

Danaher Plans to Raise Funds through Public Offering of Securities 77

Danaher Raises USD279.8 Million in Public Offering of Floating Rate Notes Due 2022 78

Danaher Raises USD671.6 Million in Public Offering of 1.2% Notes Due 2027 80

Danaher Raises USD500 Million in Public Offering of 1.65% Notes Due 2018 82

Danaher Raises USD500 Million in Public Offering of 3.35% Notes Due 2025 84

Danaher Raises USD500 Million in Public Offering of 2.4% Notes Due 2020 86

Danaher Raises USD500 Million in Public Offering of 4.375% Notes Due 2045 88

Danaher Raises USD500 Million in Public Offering of Notes Due 2017 90

Danaher Raises USD671 Million in Public Offering of 1% Notes Due 2019 92

Danaher Raises USD894.5 Million in Public Offering of 2.5% Notes Due 2025 94

Danaher Raises USD894.5 Million in Public Offering of 1.7% Notes Due 2022 96

Cepheid Completes Private Placement Of Notes Due 2021 For USD 345 Million 98

GENEWIZ to Acquire Genomic Services Business of Beckman Coulter 100

Haemonetics Completes Acquisition Of Blood Collection, Filtration And Processing Product Lines From Pall For USD 551 Million 101

Danaher to Acquire Integrated DNA Technologies 103

Danaher Acquires Phenomenex 104

Danaher Acquires Cepheid 105

Danaher Acquires Pall for USD13.8 Billion 107

Leica Microsystems to Acquire Bioptigen 109

Danaher Acquires 97% Stake in Nobel Biocare for USD2.17 Billion in Tender Offer 110

Leica Biosystems Nussloch Acquires Devicor Medical from GTCR 112

Leica Biosystems Acquires Kreatech Diagnostics 113

Leica Microsystems And Leica Biosystems Acquire Aotec Instrumentos 114

Quest Diagnostics Completes Sale Of HemoCue To Radiometer Medical For USD 300 Million 115

Danaher Completes Acquisition Of 91.6% Stake In Iris International, Diagnostic Test Maker, For USD 324 Million 117

Leica Biosystems Completes Acquisition Of Aperio Technologies 119

Beckman Coulter Acquires Blue Ocean Biomedical From Npe Systems 121

Pall Corporation Completes Acquisition Of ForteBio For USD 142.5 Million 122

Danaher Corp, Key Competitors 124

Danaher Corp, Key Employees 125

Danaher Corp, Other Locations 126

Danaher Corp, Subsidiaries 126

Danaher Corp, Business Unit 133

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Danaher Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license
Single User License
USD 250 INR 17743
Site License
USD 500 INR 35485
Corporate User License
USD 750 INR 53228

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com